InvestorsHub Logo
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

Re: frrol post# 57211

Friday, 03/18/2016 11:50:52 AM

Friday, March 18, 2016 11:50:52 AM

Post# of 463674
Hold up, I thought donepezil's MOA for Alzheimers was attributed to it being an acetylcholinesterase inhibitor, not a sigma 1 agonist. What does it coincidentally having sigma 1 binding affinity have to do with the Anavex Plus patent? I've never seen its sigma 1 affinity brought up as having anything to do with its therapeutic effect.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News